<DOC>
	<DOC>NCT03012698</DOC>
	<brief_summary>The current study aims to test the safety of Repeated Magnetic Stimulation (RMS) treatment for dry eye. Patients will be asked to undergo a one-time treatment with Epitech Corneal Magnetic Stimulation Device on one eye. Changes will be monitor for over a study period of 3 months.</brief_summary>
	<brief_title>PILOT STUDY FOR TESTING SAFETY OF REPETITIVE MAGNETIC STIMULATION FOR TREATMENT OF DRY EYE</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<criteria>1. Males and females, 1880 years old 2. Subjects with moderate to severe dry eye syndrome 3. Subjects able to understand the requirements of the protocol and provide informed consent. 1. Eyes with other ocular surface pathology which requires more treatment than eye lubricant and conventional eyelid hygiene 2. A concurrent ocular disease including ocular infection or pterygium. 3. Ocular surgery within the previous 6 months and LASIK within the previous 1 year. 4. Any ocular injury or ocular Herpes infection within past 3 months 5. Intake of certain central nervous system drugs as detailed below within last 30 days and inability to withhold such drugs for study duration. 6. Anticipated necessity to wear contact lens in the duration of the study. 7. Known history of thyroid disorders (diagnosed by physician). 8. Sleep deprivation 9. Alcoholism 10. Pregnant or nursing women 11. HIV positive person 12. Cardiac pacemakers, cardioverter defibrillators, or neurostimulators, cochlear implants, implanted medication pumps or intracardiac lines, implanted brain electrodes (cortical or deepbrain electrodes) 13. Metallic objects such as aneurysm clips or coils, stents, bullet fragments 14. Significant heart disease or cerebrovascular disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>